Development of contrast agents for imaging amyloids in type 2 diabetes – from chemical synthesis to in vivo trials
Contributors
Stransky-Heilkron, Nathalie MartineDirectors
Allémann, EricDefense date
2016-03-16Abstract
Citation (ISO format)
STRANSKY-HEILKRON, Nathalie Martine. Development of contrast agents for imaging amyloids in type 2 diabetes – from chemical synthesis to in vivo trials. Doctoral Thesis, 2016. doi: 10.13097/archive-ouverte/unige:87597
Main files (1)
Thesis
Identifiers
- PID : unige:87597
- DOI : 10.13097/archive-ouverte/unige:87597
- URN : urn:nbn:ch:unige-875973
- Thesis number : Sc. 4911
